首页> 外文期刊>BMC Medical Genomics >A hemizygous p.R204Q mutation in the ALAS2 gene underlies X-linked sideroblastic anemia in an adult Chinese Han man
【24h】

A hemizygous p.R204Q mutation in the ALAS2 gene underlies X-linked sideroblastic anemia in an adult Chinese Han man

机译:Alas2基因中的血液脂肪属P.R204Q突变在成人中汉族的X型血管囊性下潜

获取原文
           

摘要

X-linked sideroblastic anemia (XLSA) is the most common form of congenital sideroblastic anemia (CSA), and is associated with the mutations in the 5-aminolevulinate synthase 2 (ALAS2). The genetic basis of more than 40% of CSA cases remains unknown. A two-generation Chinese family with XLSA was studied by next-generation sequencing to identify the underlying CSA-related mutations. In the study, we identified a missense ALAS2 R204Q mutation in a hemizygous Chinese Han man and in his heterozygous daughter. The male proband presented clinical manifestations at 38?years old and had a good response to pyridoxine. XLSA, as a hereditary disease, can present clinical manifestations later in lives, for adult male patients with ringed sideroblasts and hypochromic anemia, it should be evaluated with gene analyses to exclude CSA.
机译:X-Lixed Siderobolas弹性贫血(XLSA)是最常见的先天性纵向血管贫血(CSA)形式,并且与5-氨基纤维素合酶2(ALAS2)中的突变有关。 超过40%的CSA病例的遗传基础仍然未知。 通过下一代测序研究了具有XLSA的两代中国的家庭,以确定相关的CSA相关突变。 在研究中,我们在杂乱的中国汉族人和他的杂合子女儿中识别出了alas2 r204q突变。 男性概念在38岁时呈现临床表现,对吡哆醇有良好的反应。 XLSA是一种遗传疾病,可以提高生命后期的临床表现,对于成年男性患有环状血管血细胞和肾小粒贫血的患者,应该用基因分析评估它以排除CSA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号